Vimarsana
Biggest News Aggregation in the World

Page 41 - Confidence Interval News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Confidence Interval. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Confidence Interval Today - Breaking & Trending Today

Microbiota-Targeted Intervention Decreases IHTC in Patients With NAFLD - Vimarsana News

Microbiota-Targeted Intervention Decreases IHTC in Patients With NAFLD

The clinical trial compared outcomes in patients with NAFLD on a resistant starch diet to a control group over a 4-month period, with results suggesting microbiota dietary supplements may improve liver conditions.

Study Details Risk of C Diff with Clindamycin, Other Antibiotics - Vimarsana News

Study Details Risk of C Diff with Clindamycin, Other Antibiotics

Results from the study found a high risk of CDI associated with clindamycin and low risk associated with doxycycline and minocycline, also highlighting variation in CDI risk within and between classes of antibiotics.

Q&A: Artificial Intelligence in Colonoscopies, With Carolina Mangas-Sanjuan, MD, PhD - Vimarsana News

Q&A: Artificial Intelligence in Colonoscopies, With Carolina Mangas-Sanjuan, MD, PhD

Carolina Mangas-Sanjuan, MD, PhD, discusses findings from her research on the use of artificial intelligence computer-aided detection in colonoscopies in this Q&A with HCPLive.

Research on AI Use in Colonoscopies Produces Mixed Results - Vimarsana News

Research on AI Use in Colonoscopies Produces Mixed Results

Results from two recent studies highlight the potential benefits and limitations of using artificial intelligence technologies in colonoscopies.

Mavacamten Use Can Reduce Need for Septal Reduction Therapy in oHCM - Vimarsana News

Mavacamten Use Can Reduce Need for Septal Reduction Therapy in oHCM

Results of the 56-week VALOR-HCM trial provide new insight into the effects of mavacamten in patients with highly symptomatic obstructive hypertrophic cardiomyopathy referred for septal reduction therapy.